These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32796405)

  • 1. Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
    Liu F; Zhu C; Gao P; Zheng S; Li C
    Anticancer Drugs; 2020 Sep; 31(8):836-846. PubMed ID: 32796405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
    Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
    Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
    Guo J; Wang M; Wang JP; Wu CX
    World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-543 impairs breast cancer cell phenotypes by targeting and suppressing ubiquitin-conjugating enzyme E2T (UBE2T).
    Li L; Li Q
    Bioengineered; 2021 Dec; 12(2):12394-12406. PubMed ID: 34787051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
    Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-498 Targets UBE2T to Inhibit the Proliferation of Malignant Melanoma Cells.
    Cao W; Ni L; Li P; Wang QX; Li MM; Huang SH; Dang NN
    Technol Cancer Res Treat; 2022; 21():15330338221082431. PubMed ID: 35243940
    [No Abstract]   [Full Text] [Related]  

  • 8. UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT.
    Zhang J; Wang J; Wu J; Huang J; Lin Z; Lin X
    Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35703356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P; Kang B; Li Y; Hao W; Ma F
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.
    Wu Y; Zhang C; Peng D; He S; Huang C; Qian J; Zhu W; Feng N; Gong Y; Li X; Zhou L
    Hum Cell; 2022 Mar; 35(2):542-556. PubMed ID: 35129808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
    Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
    J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer.
    Wen M; Kwon Y; Wang Y; Mao JH; Wei G
    Oncotarget; 2015 Sep; 6(28):25226-39. PubMed ID: 26308072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
    Zhao W; Yang S; Chen J; Zhao J; Dong J
    Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ubiquitin-conjugating enzyme E2T in the carcinogenesis and progression of pancreatic cancer.
    Zheng YW; Gao PF; Ma MZ; Chen Y; Li CY
    Oncol Lett; 2020 Aug; 20(2):1462-1468. PubMed ID: 32724389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.
    Yu H; Xiang P; Pan Q; Huang Y; Xie N; Zhu W
    Tumour Biol; 2016 Sep; 37(9):11723-11732. PubMed ID: 27020591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBE2T knockdown inhibits gastric cancer progression.
    Luo C; Yao Y; Yu Z; Zhou H; Guo L; Zhang J; Cao H; Zhang G; Li Y; Jiao Z
    Oncotarget; 2017 May; 8(20):32639-32654. PubMed ID: 28427240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.
    Qiao L; Dong C; Ma B
    J Recept Signal Transduct Res; 2022 Apr; 42(2):151-159. PubMed ID: 33435787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation.
    Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y
    Cancer Lett; 2020 Dec; 494():121-131. PubMed ID: 32590022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis.
    Zhao W; Zhao J; Guo X; Feng Y; Zhang B; Tian L
    BMC Cancer; 2021 Feb; 21(1):142. PubMed ID: 33557774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial pyruvate carrier modulates the epithelial-mesenchymal transition in cholangiocarcinoma.
    Ohashi T; Eguchi H; Kawamoto K; Konno M; Asai A; Colvin H; Ueda Y; Takaoka H; Iwagami Y; Yamada D; Asaoka T; Noda T; Wada H; Gotoh K; Kobayashi S; Koseki J; Satoh T; Ogawa K; Doki Y; Mori M; Ishii H
    Oncol Rep; 2018 Mar; 39(3):1276-1282. PubMed ID: 29286150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.